Beranda › Fibrilasi Atrium › Illinois
Uji klinis Fibrilasi Atrium di Illinois
22 studi untuk Fibrilasi Atrium mencari peserta di lokasi di Illinois.
Kota di Illinois
Teks studi resmi (Bahasa Inggris)
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
- University of Illinois Chicago, Chicago
- Northwestern University, Chicago
- Rush University Medical Center, Chicago
- dan 5 lainnya
Menerima pesertaFase 3
Usia 22 hingga 85 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT05836987A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
- Edward Hospital Midwest Cardiovascular Institute, Naperville
Menerima peserta
Usia 22 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07227532Comparing Magnesium 2g Versus 4g Versus Placebo in the Incidence of Treating AFF RVR
- Advocate Christ Medical Center Emergency Department (ACMC ED), Oak Lawn
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06376916Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
- Northshore University Health System, Evanston
- Midwest Cardiovascular Institute, Naperville
- Prairie Education and Research, Springfield
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT04088071PULSED AF Post-Approval Study
- Endeavor Health Swedish Hospital, Chicago
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06578104The Fourth Left Atrial Appendage Occlusion Study
- Northwestern University, Evanston
- Cardiovascular Medicine, PLLC and Unity Point Trinity Rock Island, Rock Island
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT05963698PREACTIVE: Preconditioning Exercise Intervention to Improve Symptoms and Quality of Life in Comorbid Atrial Fibrillation and HFpEF
- Northwestern University, Chicago
Menerima peserta
Usia 60 hingga 99 · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT07324772NOrthwestern Tempus AI-enaBLed Electrocardiography (NOTABLE) Trial
- Northwestern University, Chicago
Menerima pesertaSukarelawan sehat diterima
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT06511505Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation
- Mercyhealth Javon Bea Hospital - Riverside, Rockford
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT05723926Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
- Prairie Education & Research Cooperative, Springfield
Menerima peserta
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 15 Jul 2026 · NCT06784466Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- Anthos Investigative Site 1030, Park Ridge
- Anthos Investigative Site 9932, Rockford
- Anthos Investigative Site 9925, Winfield
Menerima pesertaFase 3
Usia 65 ke atas · Semua jenis kelamin · Diperbarui 13 Jul 2026 · NCT05712200BoxX-NoAF Clinical Trial
- Northwestern Memorial Hospital, Chicago
Menerima pesertaSukarelawan sehat diterima
Usia 65 ke atas · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT06989775Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
- NCH Hospital, Arlington Heights, Arlington Heights
- Rush University Medical Center, Chicago
- University of Illinois Hospital, Chicago
- dan 5 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Mei 2026 · NCT03907046Prevention of Postoperative Atrial Fibrillation (POAF) Using Intra-Pericardial Amiodarone
- The University of Chicago, Chicago
Menerima pesertaFase awal 1
Usia 20 hingga 85 · Semua jenis kelamin · Diperbarui 2 Mar 2026 · NCT06063538Vasoactive Drugs in Intensive Care Unit
- University of Chicago Medical Center, Chicago
Menerima pesertaFase 4
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Jan 2026 · NCT02118467Clinical and Healthcare Outcomes From Real-World Use in the United States of a Companion AI During AF Ablation
- Endeavor Health, Evanston
Menerima pesertaStudi observasional
Usia 21 ke atas · Semua jenis kelamin · Diperbarui 10 Des 2025 · NCT06056271Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
- University of Chicago, Chicago
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 14 Nov 2025 · NCT06499857Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
- Jesse Brown VA Medical Center, Chicago
- Rush University Medical Center, Chicago
- University of Illinois at Chicago, Chicago
- dan 1 lainnya
Menerima pesertaFase 4
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 24 Agu 2025 · NCT02347111Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
- North Shore University Health, Evanston
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Mei 2025 · NCT06957366Perioperative Anticoagulant Use for Surgery Evaluation -Virtual Visit (PAUSE-Virtual)
- Endeavor Health - Northshore, Evanston
Menerima pesertaStudi observasional
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 10 Mar 2025 · NCT06844227CardioFocus HeartLight Post-Approval Study
- University of Illinois, Chicago
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2024 · NCT03168659MANAGE-AF Registry -MANAGEment of Atrial Fibrillation Outcomes Registry (MANAGE-AF)
- CorVita Science Foundation (NFP), Chicago
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Jan 2024 · NCT05978466Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.